Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.

about

Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection

P2860

Q59137661-BBEE8D3E-C985-4A2A-A56C-8F21F2BE832C

P2860

Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.

Item

http://www.wikidata.org/entity/Q52629205

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@en

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@nl

type

Item

label

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@en

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@nl

prefLabel

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@en

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@nl

P1476

Lymphocyte to Monocyte Ratio a ...... inoma Without Driver Mutation.

@en

P2093

Kiyoshi Komuta

http://www.w3.org/2001/XMLSchema#string

Seigo Minami

http://www.w3.org/2001/XMLSchema#string

Shouichi Ihara

http://www.w3.org/2001/XMLSchema#string

Suguru Yamamoto

http://www.w3.org/2001/XMLSchema#string

Sung-Ho Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis

The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study

Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.

Glasgow prognostic score in patients receiving chemotherapy for non-small-cell lung cancer in stages IIIb and IV.

The revised TNM staging system for lung cancer.

The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.

Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis.

P304

13-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/WJON1084W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29581811

http://www.w3.org/2001/XMLSchema#string

P932

5862078

http://www.w3.org/2001/XMLSchema#string

Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.

about

P2860

P2860

Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932